Capitalización Total del Mercado:$00
API
ES
Oscuro

Buscar SSI/Mag7/Meme/ETF/Moneda/Índice/Gráficos/Investigación
00:00 / 00:00
Ver
    Mercados
    Índexes
    Información
    TokenBar®
    Análisis
    Macro
    Lista
Revolución de la investigación de inversión en criptomonedas impulsada por IA

Prenetics

$8.05+2.03%
PRENASDAQ
Volumen de negocios:
$289,284.49
Capitalización bursátil total:
$102,838,110.09
Capitalización de mercado en circulación:
$72,402,853.26
Tasa de rotación:
0.39%
Noticias
Anuncio
View All News
Escanea el código QR para explorar más información clave

Prenetics

PRE

Sheng Wu Yeung
Co-Founder, Chairperson & CEO
Dr. Chi Hung Tzang Ph.D.
Co-Founder & Chief Scientific Officer
Hoi Chun Lo
Chief Financial Officer
Samantha Kwok
Chief of Staff to Group CEO & Vice President of People & Operations
Dr. Senthil Kumar Sundaram M.D.
Chief Clinical Officer
Joel Neoh
Chief Consumer Officer
David Eric Vanderveen
Director & President of Americas
James DiNicolantonio
Chief Nutrition Officer, Member of Scientific & Medical Advisory Board
Prenetics
PRE
Crypto Treasury
NASDAQ
$8.05
+2.03%
Precio de cierre 07/14 16:00 EST
$8.050.00%
Precio después del horario 07/14 17:33 EST
Volumen de negocios
$289,284.49
Volumen
35,940
Tasa de rotación
0.39%
Precio máximo diario
$8.19
Precio mínimo diario
$7.91
Capitalización bursátil total
$102,838,110.09
Capitalización de mercado en circulación
$72,402,853.26
PE TTM
-2.07
PB
0.64
Información
Prenetics Global Limited is a health sciences company, which engages in the provision of early detection, prevention, and treatment of cancer. It operates through following segments: Consumer Health, Prevention and Diagnostics. The Consumer Health segment focuses on IM8 a health and wellness brand which focuses on consumer health products and Europa, a U.S. sports distribution company. The Prevention segment focuses on its CircleDNA and ACT Genomics business units. The CircleDNA business unit uses next-generation sequencing (NGS) technology for consumer deoxyribonucleic acid (DNA) test. The Diagnostics segment focuses on ACT Genomics business unit is involved in genomic profiling of solid tumors. It has a presence in the United States. The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and is headquartered in Hong Kong.
Leer más
Fecha de cotización
2021-07-16
Sector
Crypto Treasury
Bolsa
NASDAQ
Sitio web
prenetics.com
Redes sociales
twitter
Términospolítica de privacidadLibro BlancoVerificación oficialCookieBlog
sha512-gmb+mMXJiXiv+eWvJ2SAkPYdcx2jn05V/UFSemmQN07Xzi5pn0QhnS09TkRj2IZm/UnUmYV4tRTVwvHiHwY2BQ==
sha512-kYWj302xPe4RCV/dCeCy7bQu1jhBWhkeFeDJid4V8+5qSzhayXq80dsq8c+0s7YFQKiUUIWvHNzduvFJAPANWA==